Structure Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-64.7M | $105.3M |
| FY2022 | — | $-115.1M | $26.1M |
| FY2023 | — | $453.0M | $129.8M |
| FY2024 | — | $864.8M | $169.5M |
| FY2025 | — | $1.52B | $799.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-64.7M | $105.3M |
| FY2022 | — | $-115.1M | $26.1M |
| FY2023 | — | $453.0M | $129.8M |
| FY2024 | — | $864.8M | $169.5M |
| FY2025 | — | $1.52B | $799.6M |